As of July 11, confirmed cases of COVID-19 now number at more than 12.5 million around the world, including more than 3.2 million cases in the United States and more than 136,000 U.S. deaths. You can see a breakdown of coronavirus cases throughout the world and within the U.S. on the map and chart above.
Below you’ll find updates on the latest news about the coronavirus.
July 11 News Updates
Texas Dog Infected with Coronavirus
A two-year-old dog in Tarrant County, Texas has been confirmed infected with the coronavirus, WFAA reported. A private vet tested the dog after its owners became sick with COVID-19. The dog is currently healthy.
Some Houston Hospitals Are Full & Patients Are Waiting in the ERs
As ICUs in Houston, Texas fill up, many patients are having to wait in the ER for as long several hours or even multiple days, NBC News reported. The 12 busiest hospitals in the region must also sometimes tell emergency responders that they can’t accept new patients. Although this does happen from time to time even in normal circumstances, it’s happening three times as often as it did a year ago.
Florida Cook Dies Hours After Saying He Felt Good Despite COVID-19 Diagnosis
Late Wednesday night, a line cook at the Lucky Pelican in Lakewood Ranch, Florida called to say he tested positive for COVID-19, but felt OK. They said their only symptom was having a tough time breathing, but felt good overall. By the morning, they had died.
Here’s the full text of what the restaurant shared on Facebook:
Due to a COVID related incident we are closing the restaurant at this time. We were notified around 11:10am today that one of our day time line cooks passed away from COVID. This employee has not worked since last Friday, and over the weekend started having symptoms and went to get tested. They had not been back to work while waiting on their results. Late last night, this individual let us know they had received their results and they were positive. While talking to this person last night, they let us know the only symptom they had was a hard time breathing, and that they felt good about it all. Unfortunately, things changed this morning.
Since we opened backed up we have been committed to being a safe place for our staff and guests. We also believe more than ever it is important to be transparent and open with everyone. We are closing the restaurant and having our entire staff tested. Once we have all the results, we will plan our reopening. If you have been following us on Facebook, and been to our restaurant you know everyone here is going above and beyond to ensure we keep this place safe. When we reopen we will continue to strive to be a leader in this industry with safety being the highest priority. We thank you all for your understanding, and encourage you all to keep being leaders in the community in regards to safety.
Moderna’s new vaccine has shown promise in early trials of eight volunteers who received two doses, The New York Times reported. The vaccine showed a safe immune response. The trial will now be repeated with hundreds and later thousands of people in a July trial. The vaccine uses mRNA from the virus, which is a new process. The earliest a Moderna vaccine might be available would be the end of this year or early 2021.
Oxford University researchers have tested a vaccine that successfully works in monkeys and is being tested in Britain volunteers, WUSA9 reported in late April. If all goes well, the first few million doses could be ready as soon as September. The vaccine uses genes from a spikey protein to help the immune system make antibodies.
Bill Gates is funding factories that will test seven vaccine candidates to help mobilize vaccines faster, Business Insider reported in early April. He said: “Even though we’ll end up picking at most two of them, we’re going to fund factories for all seven, just so that we don’t waste time.”
A second potential COVID-19 vaccine is from Inovio, called the INO-4800 DNA vaccine. Inovio completed Phase 1 trial for a similar DNA vaccine for MERS. The Bill and Melinda Gates Foundation is backing this trial. Inovio announced positive results from two Phase I clinical trials in early July. The Phase 1 trial has now been expanded to include older participants, and Phase 2/3 may begin this summer. The Phase 1 trial had 40 healthy volunteers ages 18 to 50 who had 1 mg and 2 mg cohorts, with two doses taken four weeks apart. All were safe through week 8 and only 10 had minor adverse events, mostly just redness at the injection site. Analyses showed 94% had immunological response rates. The vaccine has also been shown to protect mice, preventing viral replication in their lungs.
On March 30, Johnson & Johnson announced that it will start human clinical trials for a vaccine in September, with the first round not being available until early 2021.
A clinical vaccine trial funded by NIH at Kaiser Permanente in Washington began on Monday, March 16. Forty-five people participated in the first round. The vaccine candidate code is mRNA-1273. As of May 1, about 2/3 of the participants had gotten their first of two doses, NBC News reported.
Israeli scientists have said they may be close to a vaccine, The Jerusalem Post reported. Scientists have been working on a vaccine against a bronchial disease that affected poultry. Dr. Chen Katz told The Jerusalem Post that out of luck, they had chosen a coronavirus as the proof of concept for their technology, and the DNA of COVID-19 is very similar.
Coronavirus Trends in the United States
An interactive map from MappingSupport.com shows recent trends in deaths per state over the last 14 and 7 days. You can view the full map here. Green means the trend is decreasing, red means the deaths are increasing. Circles show the prior 14 days and triangles show the prior seven days.
Another map sourcing the most recent news about the virus can be found here.
If you are concerned about your symptoms, talk with your doctor right away.